James Chen’s Moonshot Philanthropy: Your questions answered
The ‘growing, complex web of wellbeing challenges’ facing school students
Schools Plus has developed a number of initiatives aimed at supporting young people’s mental health in rural communities that is producing heartening outcomes.
Video: Inspiring Story – Healthy Dreaming
Healthy Dreaming is a program offering care coordination, navigation of services to empower First Nations peoples to connect with services in the Port Augusta region.
Interview with Charles Goode AC, the recently retired Chairman of The Ian Potter Foundation
In late March this year, The Ian Potter Foundation announced the retirement of Mr Charles Goode AC from its Board of Governors, effective April 2024. Charles joined the Board at the request of Sir Ian Potter in 1987 and was appointed Chairman in 1994 after the Founder's death. In this interview, Philanthropy Weekly asks the former Chairman to reflect on his 37 years of service to the Foundation.
A sector at the crossroads: how volunteering needs to change
As Australia celebrates National Volunteer Week, it's vital we create the conditions for volunteering to thrive – our society depends on it, says chair of the National Volunteering Strategy and The Smith Family CEO, Doug Taylor.
Double shot of coffee and communities gives a boost to people experiencing homelessness
There are 40 community foundations across Australia, engaged in deeply connected and life-changing work at a local level. A powerful example is the Inner North Community Foundation that provided $20,000 to the big-hearted not-for-profit St Mary’s House of Welcome in Melbourne. The grant provided a coffee machine and barista training to provide long-term prospects to people experiencing homelessness.
How impact investment is making a difference in global health equity
Impact investing is playing a critical and growing role in the development of medicines to treat ‘neglected diseases’ affecting the world’s poorest and most underserved peoples. These medicines would not otherwise be developed by the pharmaceutical industry, which is primarily driven by financial returns. Here, Mark Sullivan AO, founder and managing director of Medicines Development for Global Health, an Australian biopharmaceutical not-for-profit, describes how this finance model is supporting the development of Moxidectin – a potential gamechanger for the WHO’s roadmap to ending river blindness by 2030.